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Exposure to pesticides and heterozygote 
genotype of GSTP1-Alw26I are  
associated to Parkinson’s disease 
Exposição a pesticidas e genótipo heterozigoto de GSTP1-Alw26I associam-se à doença 
de Parkinson
Gabriela S. Longo1, Marcela S. Pinhel2, Caroline L. Sado3, Michele L. Gregório2, Gisele S. Amorim2,  
Greiciane S. Florim2, Camila M. Mazeti2, Denise P. Martins2, Fábio N. Oliveira1, Waldir A. Tognola1,  
Marcelo A. Nakazone4, Dorotéia R. S. Souza2
Parkinson’s disease (PD) is the second most common neu-
rodegenerative disorder, showing high prevalence in elderly 
patients also in Brazil, with an incidence of 150/200 cases 
per 100,000 inhabitants1. Its pathogenesis includes a com-
plex interaction among genetic and environmental factors2. 
Sporadic cases represent 85% of PD, while 10–15% are famil-
ial and less than 5% are monogenic succession, dominant 
or recessive3. Furthermore, polymorphisms have been asso-
ciated as risk factors for PD4, including those which deter-
mine enzymes involved in xenobiotics metabolism, such as 
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ABSTRACT
Objective: This study aimed to analyze the frequency of GSTP1-Alw26I polymorphism and to estimate its association with toxic substances in 
Parkinson’s disease (PD). Methods: A study group with 154 patients – subdivided into familial and sporadic PD groups – and 158 elderly individ-
uals without the disease (control group) were evaluated. GSTP1-Alw26I polymorphism was analyzed by polymerase chain reaction/restriction 
fragment length polymorphism (PCR–RFLP). Results: Patients were significantly more exposed to pesticides compared with the control group 
(p=0.0004), and the heterozygote genotype associated to exposure to pesticides also prevailed in patients (p=0.0001). Wild homozygote geno-
type was related to tobacco use (p=0.043) and alcoholism (p=0.033) in familial PD patients. Conclusion: Exposure to pesticides is associated 
to PD, whose effect can be enhanced when combined with the heterozygote genotype of GSTP1-Alw26I. Also, large genetic and environmental 
studies considering tobacco use, alcoholism, GSTP1 and PD are necessary to confirm our findings. 
Key words: glutathione transferase, genetic polymorphism, Parkinson disease, xenobiotics.
RESUMO
Objetivo: Analisar a frequência do polimorfismo GSTP1-Alw26I, assim como estimar sua associação com substâncias tóxicas na doença 
de Parkinson (DP). Métodos: A casuística avaliada foi composta por um grupo de estudo, com 154 pacientes, subdivididos em DP familial 
e esporádica, e outro com 158 idosos sem a doença (grupo controle). O polimorfismo GSTP1-Alw26I foi analisado por reação em cadeia da 
polimerase/polimorfismo de comprimento do fragmento de restrição (PCR/RFLP). Resultados: Os pacientes foram significativamente mais 
expostos a pesticidas, comparados com o grupo controle (p=0,0004), e o genótipo heterozigoto associado a exposição a pesticidas também 
prevaleceu nos pacientes (p=0,0001). O genótipo homozigoto selvagem apresentou relação com tabagismo (p=0,043) e etilismo (p=0,033) 
em pacientes com DP familial. Desse modo, a exposição a pesticidas está associada à DP, cujo efeito pode ser potencializado quando com-
binado ao genótipo heterozigoto de GSTP1-Alw26I. Estudos genético-ambientais envolvendo tabagismo, etilismo, GSTP1 e DP devem ser 
realizados em casuísticas numerosas, confirmando essa associação. 
Palavras-Chave: glutationa transferase, polimorfismo genético, doença de Parkinson, xenobióticos.
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glutathione S-transferases (GST) enzymes5. Based on bio-
chemistry, immunological and structural proprieties, the 
GST are divided into eight classes, like π (GSTP) class, 
whose gene (GSTP1) is located in 11q13 human chromo-
some. Oxidative stress activates GST, and the P1 variant 
acts on the detoxification of innumerous substances ca-
pable of causing acid nucleic, lipid and protein damage6, 
especially in the brain7. 
Individual PD risk has been associated to occupation-
al exposure to herbicides and pesticides8. There is an asso-
ciation between GSTP1 genotypes and PD in individuals ex-
posed to pesticides, which shows that the GSTP1 possibly 
affects the nigrostriatal response to neurotoxins7,8. Also, 
GSTP1 polymorphisms can influence onset age for PD4,9. 
On the other hand, there are controversies surrounding the 
risks or protection, involving GSTP1, tobacco use and PD10. 
GSTP1 polymorphisms have been first described by Board 
et  al.11 Following studies demonstrated important allelic 
differences in substrate selectivity, which usually reduces 
GSTP1 activity7,12. GSTP1-Alw26I distribution in population 
varies among different racial groups, with emphasis on Ile/
Ile genotype around 45 and 65%, followed by Ile/Val from 
30 to 45% and Val/Val from 5 to 10%, in Caucasian, Chinese 
and Korean populations13. Transitions of nucleotides 313 
(AàG), exon 5, and 341 in exon 6 (GàT) were found, involv-
ing 2 substitutions of amino acids in the active site of the 
enzyme (Ile àVal and Val à Ala). The transitions altered the 
codon 105 of wild enzyme (GSTP1*A) from ATC (Ile) to GTC 
(Val) in GSTP1*B and GSTP1*C, and modified codon 114 
from CGC (Ala) to GTG (Val), in GSTP1*C7,12. Associations 
can be observed between GSTP1*B and sporadic PD14, es-
pecially in patients older than 69 years4. Additionally, Shi 
et al.15 indicated association of GSTP1 and PD when study-
ing mice neuronal cells treated with neurotoxic substances. 
GSTP1*A prevented neuronal loss — contrary to GSTP1*B 
and GSTP1*C variants15. In this context, single nucleotide 
studies in neurodegenerative diseases can contribute to 
feature gene-environmental interactions, especially with 
GSTP1 and PD, since it affects cellular response to toxici-
ty and interferes in the penetrance of hereditary PD forms 
and the susceptibility to idiopathic PD. This study aimed to 
analyze the frequency of GSTP1-Alw26I polymorphism in 
PD, to verify its combination with toxic substances (previ-
ous exposure to pesticides, tobacco use and alcoholism) in 
patients with PD and to estimate its association with the 
disease onset. 
METHODS  
Subjects
The studied population consisted of 312 individuals, in-
dependently of gender and with mixed racial backgrounds16. 
It was separated into two groups: 
•	 Study	group	(SG)	–	n=154	patients;	62.9%	men	and	36.1%	
women;	 average	 of	 current	 age:	 68.2±11.6;	 subdivided	
into	 familial	 PD	 study	 group	 (FSG)	 –	 n=33;	 69.6%	men	
and	29.4%	women;	average	of	 current	age:	 66.1±12, and 
sporadic	PD	study	group	(SSG)	–	n=121;	61.1%	men and	
37.9%	women;	average	of	current	age:	68.8±11.5;	
•	 Control	 group	 (CG)	–	 158	 elderly	 individuals	without	
the disease or familial history of neurodegenerative 
diseases	 –	 41.1%	 men	 and	 57.9%	 women;	 average	 of	
current age: 69.0±8.9. 
The FSG was characterized by presenting at least a first 
or second degree relative with PD diagnosis, and the SSG had 
no relatives with PD. The patients were seen in Outpatient 
Neurology Clinic of Hospital de Base of São José do Rio Preto 
Medical School (FAMERP), Brazil, in the period of 2007 
through 2010. They were also subdivided into age groups, in 
order to provide analysis of the current age — ≤68 and >68 
years4 — and of the disease onset age, therefore defining 
early PD (EPD), ≤50 years, or late PD (LPD), >50 years17. 
Diagnosis of PD followed the criteria recommended by 
Jankovic18, including bradykinesia, rigidity, tremor at rest, 
postural instability, unilateral onset, response to L-dopa 
for more than five years, levodopa-induced dyskinesia, 
progressive disorder, persistent asymmetry and clinical 
course of ten years or more, as well as complementary 
tests18. The CG belonged to support groups maintained at 
the same institution. The participants underwent an in-
terview, providing information concerning familial histo-
ry of chronic-degenerative diseases (PD, Alzheimer’s dis-
ease, among others) and living habits (previous exposure 
to pesticides, tobacco use and alcoholism). Exposure to 
pesticides consisted of any previous occupational expo-
sure to such products, despite its duration8. Tobacco use 
included constant smoking of cigarettes, daily and con-
tinuously, for more than six months10. Alcoholism includ-
ed the consumption of at least 40 g of alcohol per day19. 
All subjects were informed of the nature of the study and 
confirmed their willingness to participate by signing writ-
ten consent forms. The study was approved by the Ethics 
Research Committee of the mentioned institution (opin-
ion nº 151/2008 – Certificate of Appreciation Presentation 
Ethics — CAAE – 0029.0.140.000-08).
Genetic analysis
Analyses of the genetic polymorphism, concerning allele 
and genotype frequencies for GSTP1-Alw26I, were performed 
in the Laboratory of Molecular Biology of FAMERP. Blood 
samples were collected and the genomic DNA was extract-
ed from leukocytes by standard procedures20. Polymerase 
chain reaction (PCR) was performed on an Eppendorf 
Mastercycler (Hamburg, Germany) with 25 µL reaction vol-
umes containing 20 ng of genomic DNA, 1 x PCR buffer 
(Biosystems, Curitiba, Brazil), 2.5 mM of each primer, 200 µM 
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of each dNTP, and 1.2 U of Taq DNA polymerase (Taq Gen). 
The GSTP1 gene in the DNA sequence was characterized by 
an A→G transition (Ile105àVal105) at nucleotide 313 (muta-
tion site in exon 5, codon 105), using primers, as previously 
described21. Amplification was performed according to the 
following protocol: an initial denaturation at 94ºC for 5 min-
utes followed by 40 cycles of 1 minute at 94ºC and 3 minutes 
at 62ºC, extension of 90 seconds at 72ºC and a final cycle at 
72ºC for 7 minutes. The PCR product was submitted to the 
Alw26I restriction enzyme (Gibco) (5 U per reaction tube) in 
double boiler at 37ºC, for 16 hours, and separated on 6% poly-
acrilamide gel for 50 minutes at 180 V. Fragments of 176pb, 
91pb and 85pb were identified, and compared with standard 
Ladder (Invitrogen). One 176pb fragment characterized wild 
homozygote genotype (I/I), while 176pb, 91pb and 85pb frag-
ments	demonstrated	heterozygote	genotype	(I/V);	91pb	plus	
85pb fragments reveled homozygose V/V (Figure). The DNA 
fragments were colored by GelRed Nucleic Acid Stain® and vi-
sualized by UV illumination.  
Statistical analysis
The categorical variables including the allele and geno-
type frequencies for the GSTP1 polymorphism were analyzed 
by means of the Fisher’s exact test and the χ2 test. Statistical 
analysis also included Hardy–Weinberg equilibrium, t-test 
and binary logistic regression. A level of significance was set 
at a p-value of 0.05 or less. 
RESULTS 
The alleles distribution was similar between SG (isoleu-
cine	(I)=0.68;	valine	(V)=0.31),	SSG	(I=0.66;	V=0.33),	and	CG	
(I=0.64;	V=0.35;	p>0.05;	Table	1).	However,	the	allele	I	was	sig-
nificantly	higher	in	familial	group	(FSG=0.78),	compared	with	
CG	(0.64;	p=0.	036).	Wild	homozygote	(I/I)	prevailed	in	FSG	
(63.6%)	 compared	with	SSG	 (38.0%;	p=0.013).	 I/V genotype	
predominated in SG, SSG and CG (50.6, 56.1, and 62.0%, re-
spectively;	p>0.05);	and	V/V,	in	a	reduced	frequency,	showed	
similar distribution among groups (p>0.05). FSG exhib-
ited the pattern predicted by Hardy–Weinberg equilibri-
um (χ²=0.29;	p=0.90),	different	 from	SG	 (χ²=5.01;	p=	0.025),	
SSG (χ²=7.82;	p=0.005)	and	CG	(χ²=19.9;	p<0.0001).	
Table 2 shows socio-demographic data such as age, sex 
and lifestyle (tobacco use, alcoholism and previous contact 
with pesticides). Age was similar among groups (p>0.05), 
whereas male prevailed in SG (62.9%), FSG (69.6%) and SSG 
(61.1%),	compared	with	CG	(41.1%;	p=0.002;	p=0.005;	p=0.001,	
respectively). Tobacco use and alcoholism had low frequency 
and were similar among the groups (p>0.05). On the other 
hand, patients were more exposed to pesticides (50%) than 
controls	 (25%;	p=0.0004),	 as	well	 as	 SSG	 (53.0%)	 compared	
with	CG	(25%;	p=0.0001),	meanwhile	FSG	(38.7%)	showed	no	
significant	difference	from	CG	(25%;	p=0.226).
Tables 3 to 5 present the groups distribution according 
to genetic variants and environmental factors. SG, SSG and 
CG were similar concerning tobacco use (Table 3) and alco-
holism (Table 4). However, in FSG and smoker patients there 
Figure. GSTP1-Alw 26I electrophoresis.
GSTP1- Alw26I FSG (a)
* 
n=33
SSG (b)* 
n=121
SG (c)* 
n=154
CG (d)* 
n=158
Genotype n % n % n % n %
I/I 21 63.6 46 38.0 67 43.5 53 33.5
I/V 10 30.3 68 56.1 78 50.6 98 62.0
V/V 2 6.0 7 5.7 9 5.8 7 4.4
Total 33 100 121 100 154 100 158 100
Allele n AF n AF n AF n AF
I 52 0.78 160 0.66 212 0.68 204 0.64 
V 14 0.21 82 0.33 96 0.31 112 0.35
Total 66 1.00 242 1.00 308 1.00 316 1.00
Table 1. Genotypic and allelic frequencies for GSTP1-Alw26I in patients with Parkinson’s disease, grouped in study group, familial 
or sporadic, and individuals without the disease, or controls. 
FSG: familial Parkinson’s disease study group; SSG: sporadic Parkinson’s disease study group; SG: study group; CG: control group; axd: FSGxCG; bxc: SSGxSG; bxd: 
SSGxCG; cxd: SGxCG; AF: absolute frequency; p-value: I/I – axd=0.002; axb=0.013; bxd= 0.517; cxd=0.090; I/V – axd=0.001; axb=0.014; bxd=0.390; cxd=0.055; 
V/V – axd=0.655; axb=1.000; bxd=0.812; cxd=0.757; I/V – axd=0.036; axb=0.068; bxd=0.769; cxd=0.294. χ2: or Fisher’s tests, p<0.05 significance.
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Genotype
SG (a) FSG (b) SSG (c) CG (d)
p-value
T nT T nT T GEEnT T nT 
n % n % n % n % n % n % n % n % axd bxd cxd bxc
I/I 24 43.6 40 7.8 6 75 13 56.5 18 38.9 26 39.3 16 32.0 26 30.5 0.950 0.839 0.963 0.676
I/V 29 52.7 42 47.1 2 25 8 34.7 27 57.4 35 53.0 34 68.0 53 62.3 0.950 0.313 0.705 0.297
V/V 2 3.6 7 44.9 0 0 2 8.6 2 4.2 5 7.5 0 0 6 7.0 0.485 0.461 1.000
Total 55 100 89 100 8 100 23 100 47 100 66 100 50 100 85 100
FSG: familial Parkinson’s disease study group; SSG: sporadic Parkinson’s disease study group; SG: study group; CG: control group; T: smokers; nT: no smokers; 
Smokers intra-group analysis (II x -/V) – axd: SGxCG=0.305; bxd: FSGxCG=0.043; cxd: SSGxCG=0.662; bxc: FSGxSSG=0.067.
p-value (χ2 or Fisher): significance for p<0.05.
Table 3. Distribution of Parkinson’s disease patients, grouped in study group, familial or sporadic, and individuals without the 
disease, smokers and no smokers, according to their genotypes for GSTP1-Alw26I.  
Genotype
SG (a) FSG (b) SSG (c) CG (d)
p-value
A nA A nA A nA A nA
n % n % n % n % n % n % n % n % axd bxd cxd bxc
I/I 22 47.8 42 42.8 8 72.7 11 55 14 40 30 38.4 12 32.4 30 30.6 0.679 0.454 0.926 0.618
I/V 20 43.4 51 52.4 2 18.1 8 40 18 51.4 44 54.4 25 67.5 62 63.2 0.937 0.721 0.968 0.715
V/V 4 8.6 5 5.1 1 9.0 1 5 3 8.5 4 5.1 0 0 6 6.1 0.103 0.250 0.192 1.000
Total 46 100 98 100 11 100 20 100 35 100 78 100 37 100 98 100
Table 4. Distribution of Parkinson’s disease patients, grouped in study group, familial or sporadic, and individuals without the 
disease, alcoholics and no alcoholics, according to their genotypes for GSTP1-Alw26I.
FSG: familial Parkinson’s disease study group; SSG: sporadic Parkinson’s disease study group; SG: study group; CG: control group; A: alcoholics; nA: no alcoholics; 
Alcoholics intra-group analysis (II x -/V) – axd: SGxCG=0.232; bxd: FSGxCG=0.033; cxd: SSGxCG=0.672; bxc: FSGxSSG=0.082. p-value (χ2 or Fisher): significance 
for p<0.05.
SG (a)* 
n=154
FSG (b)* 
n=33
SSG (c)* 
n=121
CG (d)* 
n=158
n % n % n % n %
Age (years)
Median 68.2
11.6
66.1
12.0
68.8
11.5
69.0
8.9Standart deviation 
Sex
Male 97 62.9 23 69.6 74 61.1 65 41.1
Female 57 37.0 10 30.3 47 38.8 93 58.8
Smoking
Yes 55 38.1 8 25.8 47 41.5 50 37.0
No 89 61.8 23 74.1 66 58.4 85 62.9
Total 144 100 31 100 113 100 135 100
Alcoholism
Yes 46 31.9 11 35.4 35 30.9 37 27.4
No 98 68.0 20 64.5 78 69.0 98 72.5
Total 144 100 31 100 113 100 135 100
Previous contact with pesticides
Yes 72 50 12 38.7 60 53.0 21 25.0
No 72 50 19 61.3 53 47.0 63 75.0
Total 144 100 31 100 13 100 84 100
FSG: familial Parkinson’s disease study group; SSG: sporadic Parkinson’s disease study group; SG: study group; CG: control group; axd: SGxCG; bxc: FSGxSSG; 
bxd: FSGxCG; cxd: SSGxCG; p-value: Age – axd=0.479; bxc=0.54; bxd=0.196; cxd=0.830; Sex – axd=0.0002; bxc=0.485; bxd=0.005; cxd=0.001; Smoking – 
axd=0.939; bxc=0.163; bxd=0.330; cxd=0.547; Alcoholism – axd=0.485; bxc=0.795; bxd=0.499; cxd=0.634; Pesticides – axd=0.0004; bxc=0.223; bxd=0.226; 
cxd=0.0001. χ2: or Fisher’s tests, p<0.05 significance.
Table 2. Social – demographic data in patients with Parkinson’s disease, grouped in study group, familial or sporadic, and 
individuals without the disease, or controls.  
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was a 75% prevalence of wild homozygote genotype (I/I), 
compared	 with	 GC	 (32%;	 p=0.043).	 I/I	 genotype	 also	 pre-
vailed	in	FSG	and	alcoholic	patients	(FSG=72.7%;	CG=	27.4%;	
p=0.033).	Heterozygote	genotype	(I/V)	combined	with	pesti-
cides	prevailed	in	SG	(60.5%=43	exposed	patients/71	hetero-
zygote patients, versus	CG=24.0%=13	exposed	individuals/54	
heterozygote	individuals;	p=	0.0001).	Likewise,	I/V	presented	
higher frequency combined with exposure to pesticides in 
SSG	(59.6%=37	exposed	patients/62	heterozygote	patients);	
and	FSG	(60%=6	exposed	patients/10	heterozygote	patients),	
compared	 with	 GC	 (24.0%=13	 exposed	 individuals/54	 het-
erozygote	individuals;	p=0.	0002	and	p=0.053,	respectively).	
Earlier PD or late PD patients presented similar distri-
bution for GSTP1-Alw26I genotype (p>0.05), also when com-
bined with tobacco use and alcoholism (p>0.05). On the oth-
er hand, heterozygote genotype (I/V) prevailed in patients 
with earlier PD and previous exposure to pesticides (90%), 
compared with late PD, also exposed (63.9%), with no signif-
icant	 difference	 between	 groups,	 though	 (p=0.092).	 Results	
were also similar considering genotype distribution between 
≤68 and >68 years patients (p>0.05). 
The logistic regression analysis for sex, age, tobacco 
use, alcoholism, exposure to pesticides and GSTP1-Alw26I 
genotypes	 (Logit	 Y=	 -0.397997	 +1.031093	 sex	 +1.808364	
age -0.562085	smoking	-0.130537	alcoholism	+1.109846	pes-
ticide -0.654763	genotype)	pointed	male	sex	(p=0.0034),	age	
>68	years	(p<0.0001)	and	exposure	to	pesticides	(p=0.001)	as	
risk factors for PD.  
DISCUSSION 
In this study, with mixed ethnic Brazilian casuistics, the 
GSTP1-Alw26I polymorphism genotypic distribution is sim-
ilar to that in the general population, considering distinct 
racial groups8,13,14. Heterozygote genotype (I/V) prevailed 
among familial or sporadic PD patients, and also in the con-
trol group. This distribution, although supported by some au-
thors8, is different from other studies4,14,22. The V/V homozy-
gote did not show any association with PD, which was also 
reported by other authors8,14. The presence of the Val105 (V) 
allelic variant of GSTP1 is associated with the decrease of the 
enzyme activity, which would favor dopaminergic neurons 
degeneration in PD4,15. However, in this study, the wild geno-
type (I/I) presented association with familial PD. Studies in-
volving GSTP1 polymorphisms and familial PD are scarce9, 
making population comparisons difficult.
In this study, the familial PD group exhibited the pat-
tern predicted by Hardy–Weinberg equilibrium, different 
from the pattern of other groups studied, which is also ob-
served in other case-control studies of different genetic 
polymorphisms23,24. The selection criteria adopted in this 
study was to form groups of older individuals, since PD 
mainly affects elderly patients. Furthermore, the disease 
is associated with occupational exposure to pesticides, 
which is more common in males. This was confirmed by 
the logistic regression analysis that demonstrated male 
sex, age >68 years and exposition to pesticides as risk fac-
tors for PD.  Therefore, the profiles of patient and control 
groups do not represent the general population concern-
ing sex and age, influencing the distribution of genotypes. 
FSG also included younger patients, suggesting better 
representation of the general population. Additionally, ab-
sence of Hardy-Weinberg equilibrium would be expected 
for a wide group of genetic diseases, considering the gene 
contribution — although modest — for complex diseas-
es. However, given the numerous candidate gene stud-
ies in different cases, genetic markers showing  disequi-
librium are scarce, which allows investigators to ignore 
the distribution of genotypes suggesting disequilibrium, 
therefore ignoring valuable information to identify casual 
polymorphisms23. 
The polymorphism GSTP1-Alw26I, when related to to-
bacco use and alcoholism, was the same in the SG, SSG 
and CG groups, as well as in other studies involving smok-
ing and PD10,22,25. On the other hand, there are references of 
tobacco protection in PD, including haplotypes of GSTP110. 
The catalytic efficiency of the GSTP1 variants differs from 
that of the wild type, and it varies according to the charac-
teristics of the substrates, manly distinct26. This explains the 
protective effect of the mutant allele regarding diol epoxides 
found in tobacco products10, in contrast with its reduced ef-
fects upon detoxification of pesticides7. In this study, there 
was an association between smoking and wild homozygote 
Genotype
SG (a) FSG (b) SSG (c) CG (d)
p-value
P nP P  nP P  nP  P nP 
n % n % n % n % n % n % n % n % axd bxd cxd bxc
I/I 23 31.9 41 56.9 5 41.6 14 73.6 18 30.0 26 49.0 7 33.3 18 28.5 0.643 0.901 0.416 0.393
I/V 43 59.7 28 38.8 6 50 4 21.0 37 61.6 25 47.1 13 61.9 41 65.0 0.0001 0.053 0.0002 1.000
V/V 6 8.3 3 4.1 1 8.3 1 5.2 5 8.3 2 3.77 1 4.7 4 6.3 0.265 1.000 0.242 1.000
Total 72 100 72 100 12 100 19 100 60 100 53 100 21 100 63 100
Table 5. Distribution of Parkinson’s disease patients, grouped in study group, familial or sporadic, and individuals without the 
disease, with or without previous contact with pesticides, according to their genotypes for GSTP1-Alw26I.    
FSG: familial Parkinson’s disease study group; SSG: sporadic Parkinson’s disease study group; SG: study group; CG: control group; P: with previous contact with 
pesticides; nP: without previous contact with pesticides. Pesticides intra-group analysis (II x -/V) – axd: SGxCG=0.904; bxd: FSGxCG=0.918; cxd: SSGxCG=0.991; 
bxc: FSGxSSG=0.503. χ2 or Fisher’s exact test: significance for p<0.05.
451Gabriela S. Longo et al. Parkinson’s disease: genetic and exposure to pesticides
genotype in familial PD patients, confirming the studies by 
Pal et al.26 and De Palma et al.10. 
Likewise, association between I/I genotype and alcohol-
ism was found in familial PD patients. Admittedly, alcohol 
abuse damages brain structures and their functions, which 
leads to neurodegeneration27. The effects of alcohol in the 
brain are not uniform, affecting mainly the pre- frontal cor-
tex, the hippocampus, the cerebellum, the substantia nigra 
and the glia27. Dopaminergic neurons in the substantia nig-
ra are believed to be damaged by alcohol during intrauterine 
development27,28.  The effect of alcohol in this region is still 
unclear concerning brains are already developed28. Studies 
involving GSTs, alcohol, substantia nigra and PD are rare. 
On the other hand, GST activity is known to be reduced in 
hepatocytes due to alcohol exposure29. Retinoid X receptor 
α-deficient (RXRα KO) mice, which are more susceptible to 
ethanol-induced hepatotoxicity, showed a 56% decrease in 
GSTP1 activity, which demonstrates its role in the detoxifi-
cation  of alcohol in the liver29. Therefore, GSTP1 polymor-
phisms seem to intensify the damage caused by ethanol in 
hepatocytes, leading to alcoholic cirrhosis and pancreatitis19. 
The present study revealed the combination of the wild geno-
type (I/I) with alcoholism in familial PD patients. The small 
casuistic of familial patients analyzed in this study speaks in 
favor of detailed studies involving familial PD patients, GSTP1 
polymorphisms and lifestyle. 
PD patients group showed more exposure to pesticides, 
especially concerning the combination of such exposure and 
the heterozygote genotype (I/V). The GST enzymes, mainly 
GSTP14,7, are involved in metabolizing pesticides8. Studies 
demonstrated that some kinds of pesticides, like rotenone, 
can cause PD-like symptoms30, acting as inhibitors of mito-
chondrial I complex.  In this case, there is some evidence that 
dopaminergic neurons are particularly vulnerable to mito-
chondrial dysfunction30. The toxin is captured by dopamine 
and noradrenalin transporters and is accumulated in the cy-
tosol, causing cellular death induced by oxidative stress and 
deficiency of the breathing mitochondrial chain30. Shi et al.15 
demonstrated protection of the neuronal dopaminergic cells 
of mice exposed to rotenone by the expression of the wild 
GSTP1 (I allele), and reduced protection by its variants ex-
pression (V allele). These data were confirmed in the present 
study, by means of the association of GSTP1-Alw26I heterozy-
gote, exposure to pesticides and PD.    
The V allele have been associated to late onset PD, given 
its prevalence in patients with more than 68 years of age4,15, de-
spite the lack of association between GSTP1 polymorphisms 
and PD onset age in North American casuistics14. In this study, 
there was no association of GSTP1-Alw26I genotypes, current 
age and PD onset age. However, considering onset age, previous 
exposure to pesticides and the presence of the mutant allele of 
GSTP1-Alw26I, the group with earlier PD (PD onset before than 
50 years) was significant, if compared with those with late PD 
onset age, which requires confirmation in wide casuistics. 
The regulation of the apoptotic kinase c–jun termi-
nal ( JNK) by protein–protein  direct binding and the de-
toxification of electrophilic compounds by conjugation 
with reduced glutathione have been the mainly reported 
GSTP1 functions15. The former mechanism could be asso-
ciated to late onset PD in GSTP1 heterozygote patients. 
The GSTP1 enzyme would play an important role in the 
thermal shock protein system — also responsible for regu-
lating JNK apoptosis4 failed to act due to aging. Shi et al.15 
demonstrated that in the brains of mice treated with rote-
none there was no activation of the JNK pathway of apop-
tosis. High level of oxidative stress was detected though, 
and GSTP1 detoxification with reduced glutathione was 
essential for neuron protection in this case15. That would 
explain the possible relation suggested in this study, be-
tween heterozygote genotype for GSTP1 in patients with 
previous exposure to pesticides, and the earlier PD, to be 
confirmed in further studies.  
In conclusion, this study confirms the association among 
PD, male sex, ageing and exposure to pesticides, whose ef-
fects can be enhanced in combination with I/V genotype of 
GSTP1-Alw26I, reinforcing the relation between genetic poly-
morphisms involved in xenobiotics metabolism and environ-
mental factors in PD. This is confirmed by the prevalence of 
the I/I genotype and tobacco or alcohol use only in the FSG, 
suggesting that different effects of GSTP1-Alw26I variants, 
due to lifestyle, determine specific subgroups of patients, 
which may be confirmed in other casuistics.   
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